Atomoxetine for the Treatment of Newly Diagnosed Adults with Adhd - a Cost Effectiveness Analysis in Spain
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.1257
https://www.valueinhealthjournal.com/article/S1098-3015(14)03187-8/fulltext
Section Title :
Disease-Specific Studies
Section Order :
745
First Page :
A457
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03187-8&doi=10.1016/j.jval.2014.08.1257